GW&K Investment Management LLC Sells 186,437 Shares of HealthEquity, Inc. (NASDAQ:HQY)

GW&K Investment Management LLC lessened its position in HealthEquity, Inc. (NASDAQ:HQY) by 23.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 604,471 shares of the company’s stock after selling 186,437 shares during the period. GW&K Investment Management LLC owned 0.70% of HealthEquity worth $57,999,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Holocene Advisors LP purchased a new stake in shares of HealthEquity during the third quarter worth about $1,246,000. GSA Capital Partners LLP purchased a new stake in HealthEquity in the 3rd quarter worth approximately $638,000. Natixis Advisors LLC grew its position in shares of HealthEquity by 29.8% in the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after buying an additional 48,009 shares during the last quarter. Vaughan Nelson Investment Management L.P. grew its position in shares of HealthEquity by 36.7% in the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 843,423 shares of the company’s stock worth $69,034,000 after buying an additional 226,563 shares during the last quarter. Finally, Loomis Sayles & Co. L P increased its stake in shares of HealthEquity by 2.2% during the third quarter. Loomis Sayles & Co. L P now owns 1,126,645 shares of the company’s stock valued at $92,216,000 after buying an additional 24,665 shares during the period. Institutional investors own 99.55% of the company’s stock.

Insider Transactions at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 39,000 shares of company stock worth $3,895,788. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Stock Up 1.4 %

Shares of NASDAQ:HQY opened at $107.05 on Friday. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The stock has a market capitalization of $9.28 billion, a price-to-earnings ratio of 98.21, a PEG ratio of 1.60 and a beta of 0.55. The stock has a fifty day simple moving average of $104.84 and a two-hundred day simple moving average of $93.08. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the firm posted $0.40 earnings per share. On average, research analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on HQY shares. Bank of America raised their price target on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Wells Fargo & Company raised their target price on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday. Royal Bank of Canada boosted their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th. Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target for the company. Finally, Raymond James lifted their price objective on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $113.54.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.